Fitness

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune…

5 months ago

BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management

BioAdaptives, Inc. BioAdaptives’ AI-based Fit Your Outfit app LAS VEGAS, NV, Dec. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –…

6 months ago

Success Beyond Startup: Nurturing Growth as a Co-Founder with Kilo Health

VILNIUS, LITHUANIA / ACCESSWIRE / December 20, 2023 / From developing healthcare systems to personalized fitness apps such as Joggo,…

6 months ago

NextGen Healthcare Named a Leader in IDC MarketScape: U.S. Electronic Health Record 2023-2024 Vendor Assessment

REMOTE-FIRST COMPANY/IRVINE--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, Inc., a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it has been…

6 months ago

CorVive Unveils New Keto Supplement, Elevating Wellness with a Science-Backed Formula

PLANO, TX / ACCESSWIRE / December 14, 2023 / In a significant expansion of its acclaimed wellness portfolio, CorVive has…

6 months ago

Hidden Scar Tummy Tuck: Achieving Sleek Abs with Less Scarring

NEWPORT BEACH, CA / ACCESSWIRE / December 7, 2023 / The desire to improve physical appearance and boost self-confidence often…

6 months ago

Zepp Health Celebrates 10 Years of Innovation with a Purpose-Led Brand Refresh and Expanded Wellness Healthcare Solutions

MILPITAS, Calif.--(BUSINESS WIRE)--Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, commemorates its…

6 months ago

Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023

SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of…

6 months ago

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as…

6 months ago

Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution

NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical…

6 months ago